Selective growth-hormone secretagogue that stimulates pituitary GH release without raising cortisol or prolactin levels.
Ipamorelin is a pentapeptide growth-hormone secretagogue that acts as a selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R) in the anterior pituitary gland. Unlike other GH secretagogues such as GHRP-6 or hexarelin, Ipamorelin is highly selective — it stimulates growth hormone release without significantly elevating cortisol, prolactin, or aldosterone levels. This selectivity makes it one of the safest and most predictable peptides in the GH-axis category.
When administered, Ipamorelin binds to GHS-R receptors on somatotroph cells in the pituitary, triggering a pulse of growth hormone that mimics the body's natural secretion pattern. This pulsatile release is critical because it preserves the physiological feedback loops that regulate GH production, avoiding the constant elevation (and subsequent receptor downregulation) seen with exogenous GH administration. The result is a natural-feeling optimization of GH levels that supports fat metabolism, lean muscle maintenance, sleep architecture, and systemic recovery.
Ipamorelin is frequently prescribed alongside CJC-1295 (a GHRH analogue) to create a synergistic effect: CJC-1295 amplifies the GH pulse amplitude while Ipamorelin increases pulse frequency. This combination produces a more robust and sustained elevation in GH and IGF-1 levels than either peptide alone.
Stimulates natural pituitary GH release in a pulsatile pattern, optimizing growth hormone levels without disrupting the hypothalamic-pituitary axis.
Elevated GH levels promote lipolysis, helping the body mobilize stored fat for energy while preserving lean muscle tissue during caloric deficit.
Supports muscle protein synthesis and nitrogen retention, contributing to improved body composition and lean mass maintenance with training.
GH is naturally released during deep sleep. Ipamorelin supports this process, and many patients report improved sleep depth and more restorative rest.
Enhanced GH and IGF-1 levels support faster recovery from training, injury, and daily physical stress through improved tissue repair signaling.
Experiencing the natural decline in GH production with age and seeking to restore youthful recovery capacity, body composition, and performance.
Looking to improve the ratio of lean muscle to body fat through GH optimization alongside a training and nutrition program.
Struggling with poor sleep quality or slow recovery from training, and wanting to support the body's natural overnight repair mechanisms.
Ipamorelin is included in several physician-designed protocol stacks:
Ipamorelin was first characterized in 1998 by Novo Nordisk and has since been the subject of multiple clinical trials demonstrating its ability to selectively stimulate GH release without the side effects associated with non-selective GH secretagogues. Phase II clinical trials in post-surgical patients demonstrated improved GI recovery and reduced hospital stay. Its favorable safety and selectivity profile has made it one of the most widely prescribed peptides in anti-aging and performance medicine.
No. Ipamorelin stimulates your body's own pituitary gland to release growth hormone naturally, preserving the pulsatile pattern and feedback mechanisms. Exogenous GH bypasses these controls.
CJC-1295 amplifies GH pulse amplitude while Ipamorelin increases frequency. Together, they produce a stronger, more sustained GH response than either peptide alone, with minimal side effects.
Ipamorelin is typically administered before bed to align with the body's natural nocturnal GH pulse. Your physician will determine the optimal dosing schedule for your goals.
No. One of Ipamorelin's key advantages is its selectivity — it stimulates GH release without significantly elevating cortisol, prolactin, or aldosterone, unlike less selective GH secretagogues.
Many patients notice improved sleep quality within the first 1–2 weeks. Body composition changes typically become apparent over 4–8 weeks with consistent use alongside a training program.
Individual results may vary. This information is for educational purposes only. All peptide therapies require a physician evaluation and prescription.
A physician will evaluate whether Ipamorelin is right for your performance and recovery goals.
Check Your Eligibility →